Genmab

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Genmab and other ETFs, options, and stocks.

About GMAB

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. 

CEO
Jan G. J. van de Winkel
CEOJan G. J. van de Winkel
Employees
1,212
Employees1,212
Headquarters
Copenhagen, Capital Region
HeadquartersCopenhagen, Capital Region
Founded
1998
Founded1998
Employees
1,212
Employees1,212

GMAB Key Statistics

Market cap
29.08B
Market cap29.08B
Price-Earnings ratio
36.20
Price-Earnings ratio36.20
Dividend yield
Dividend yield
Average volume
545.40K
Average volume545.40K
High today
$44.55
High today$44.55
Low today
$44.14
Low today$44.14
Open price
$44.33
Open price$44.33
Volume
155.26K
Volume155.26K
52 Week high
$44.56
52 Week high$44.56
52 Week low
$26.19
52 Week low$26.19

Analyst ratings

58%

of 26 ratings
Buy
57.7%
Hold
34.6%
Sell
7.7%

GMAB Earnings

$0.00
$0.54
$1.09
$1.63
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Feb 15
ActualExpected Feb 15
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.